Orthofix shareholders approve stock issuance for SeaSpine merger

Orthofix Medical Inc.

17.1M votes for (97.7% of votes cast); 264k against, 131k abstain.
Issuance of Orthofix common stock to SeaSpine stockholders as part of Oct 10, 2022 merger agreement.
Special meeting quorum achieved with 87.54% of 20.0M outstanding shares represented.
Proposal to adjourn meeting not needed because sufficient votes were cast.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Orthofix Medical Inc. shareholders approved Approval of issuance of Orthofix common stock to SeaSpine stockholders in connection with the merger. at the 2023-01-04 meeting.

Proposal: merger approval
Outcome: passed
Meeting: 2023-01-04

Exact text from the filing

Proposal 1: Orthofix Share Issuance. To approve the issuance of Orthofix common stock, par value $0.10 per share, to SeaSpine stockholders in connection with the merger, as contemplated by the Agreement and Plan of Merger, dated as of October 10, 2022, by and among Orthofix Medical Inc., Orca Merger Sub Inc. and SeaSpine Holdings Corporation. For Against Abstain 17,121,777 264,278 131,200

View on SEC.gov

150 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Orthofix Medical Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-001527

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.